eCite Digital Repository

Fertility drugs and cancer


Venn, AJ and Healy, DL, Fertility drugs and cancer, Reproductive Medicine Review, 6, (3) pp. 185-198. ISSN 0962-2799 (1997) [Refereed Article]


Copyright Statement

Copyright 1997 Cambridge University Press

DOI: doi:10.1017/S0962279900001514


The short-term risks of fertility drug treatment, such as ovarian hyperstimulation syndrome, are well recognised by clinicians providing infertility treatment. There is uncertainty, however, about whether there are any longterm risks such as an increased risk of breast or gynaecological cancer. The possibility of such long-term risks is sometimes a concern for couples who are considering or receiving infertility treatment and their concerns need to be discussed using the best available evidence. The need for appropriate evaluation of long-term health effects of treatment with fertility drugs, including cancer, has been highlighted in major reviews of infertility treatments in Australia and Canada.

Item Details

Item Type:Refereed Article
Research Division:Biomedical and Clinical Sciences
Research Group:Reproductive medicine
Research Field:Reproduction
Objective Division:Health
Objective Group:Specific population health (excl. Indigenous health)
Objective Field:Women's and maternal health
UTAS Author:Venn, AJ (Professor Alison Venn)
ID Code:134509
Year Published:1997
Deposited By:Menzies Institute for Medical Research
Deposited On:2019-08-15
Last Modified:2019-09-11
Downloads:24 View Download Statistics

Repository Staff Only: item control page